CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • November 8th, 2023 • Assertio Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 8th, 2023 Company Industry JurisdictionWHEREAS, Parent, Spectrum Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Spade Merger Sub 1, a Delaware corporation and wholly owned subsidiary of the Parent (“Merger Sub”) have entered into an Agreement and Plan of Merger dated as of April 24, 2023 (as amended, restated, supplemented or otherwise modified from time to time pursuant to its terms, the “Merger Agreement”), pursuant to which Merger Sub will merge with and into the Company, with the Company being the surviving corporation (the “Surviving Corporation”).